These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5718494)

  • 1. [Norethisterone acetate in the therapy of functional hemorrhages of the endometrium].
    Montemagno U
    Arch Ostet Ginecol; 1968; 73(4):421-40. PubMed ID: 5718494
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and biological experience with a new norsteroid: SH 513].
    Lévrier M
    Gynecol Prat; 1964; 15(1):29-36. PubMed ID: 5878723
    [No Abstract]   [Full Text] [Related]  

  • 3. Current thoughts on the management of dysfunctional uterine bleeding.
    Pria SD; Audebert A; Greenblatt RB
    Am J Obstet Gynecol; 1969 Dec; 105(8):1185-91. PubMed ID: 5360247
    [No Abstract]   [Full Text] [Related]  

  • 4. [The estroprogestinic combination norethisterone-ethinyl estradiol in non-gravidic gynecologic therapy].
    Montemagno U
    Arch Ostet Ginecol; 1967; 72(5):493-510. PubMed ID: 5608189
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hormonally induced bleeding abnormalities and psychovegetative disorders with a two-phase preparation].
    Warnecke G; Lachnit U
    Ther Ggw; 1974 Feb; 113(2):254-5 passim. PubMed ID: 4596827
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the behavior of the hemostatic system during hormonal treatment of menstruation disorders].
    Musiatowicz J; Bielecki M; Jezuita J; Wielkopolan J
    Wiad Lek; 1968 Jul; 21(13):1119-23. PubMed ID: 5670518
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estrogen-gestagen therapy with hormonally induced uterine bleeding. II. Therapeutic use of Klimovan].
    Cséffalvay T; Klose S
    Dtsch Gesundheitsw; 1965 Jul; 20(29):1334-9. PubMed ID: 5319408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment of patients with dysfunctional uterine hemorrhages with different types of synthetic progestins].
    Sotnikova EI
    Sov Med; 1975 Jun; (6):31-5. PubMed ID: 1162470
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dysfunctional uterine bleeding. Hormonal management with chlormadinone acetate].
    Olivas Mendoza G; Santos Martínez A; Corral Olaguez M; Iduñate y Carlos DM; Hernández Ayup S
    Ginecol Obstet Mex; 1978 Dec; 44(266):463-71. PubMed ID: 84774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of functional uterine hemorrhage and luteinic insufficiency with vinylestrenolone].
    Rubio LB
    Minerva Ginecol; 1965 Nov; 17(21):1061-3. PubMed ID: 5880760
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of synthetic steroid preparations for hemostasis and normalization of menstrual function in juvenile hemorrhages].
    Kuznetsova MN; Antipina NN; Zagorskaia EA
    Vopr Okhr Materin Det; 1978 Feb; 23(2):77-80. PubMed ID: 347706
    [No Abstract]   [Full Text] [Related]  

  • 13. Experiences with Norcolut (a new therapeutic gestagen).
    Altmayer P; Szabó J; Sas M
    Ther Hung; 1978; 26(2):53-5. PubMed ID: 684654
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the use of a new synthetic estrogen-progestin combination in the treatment of functional gynecologic disorders].
    Fiorino S; Rossi T; Scio A
    Quad Clin Ostet Ginecol; 1966 May; 21(5):282-310. PubMed ID: 5988967
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lutenyl and menstrual disorders. A hospital study].
    Cohen A; Engelmann P; Erny R; Favier M; Ghéron G
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):741-3. PubMed ID: 3206099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of a new corpus luteum steroid].
    Lange-Sundermann K
    Arzneimittelforschung; 1969 Aug; 19(8):1273-7. PubMed ID: 5820292
    [No Abstract]   [Full Text] [Related]  

  • 17. [The pattern of fibrinolytic disorders in uterine blood and the effect of PAMBA]].
    Flähmig M; Sieg U; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):41-50. PubMed ID: 4173879
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic potentials of treating uterine hemorrhages with norethisterone acetate].
    Tokin R; Dimov I; Dzhebarov S
    Akush Ginekol (Sofiia); 1983; 22(1):56-8. PubMed ID: 6881473
    [No Abstract]   [Full Text] [Related]  

  • 19. Norethindrone--a review of therapeutic applications.
    Taitel HF; Kafrissen ME
    Int J Fertil Menopausal Stud; 1995; 40(4):207-23. PubMed ID: 8520623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of Sophia-A, combined low-dosage preparation of norethisterone and mestranol].
    Akasu F; Akasofu K; Hayashi I; Fujii I; Shimada H
    Horumon To Rinsho; 1969 Oct; 17(10):871-5. PubMed ID: 5390548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.